Grundium is pleased to announce a strategic commercial partnership with Bioanalytica, a long-established provider of diagnostic and laboratory technologies serving Greece and Cyprus.
With more than 35 years in the healthcare market and over 20 years of focus in Anatomical Pathology, Bioanalytica supports a broad customer base across public hospitals, private diagnostic laboratories, and reference pathology centers throughout the region.
Bioanalytica also brings proven experience in digital transformation. The team has already delivered successful Anatomical Pathology laboratory digitalization projects in Greece, implementing integrated workflows that combine equipment, software, training, and technical support. This practical, deployment-level expertise makes Bioanalytica a strong partner for expanding access to Grundium’s digital slide scanning solutions.
Through the collaboration, Bioanalytica will offer the Grundium Ocus® series to pathology laboratories in Greece and Cyprus, expanding its digital pathology portfolio with compact, high-performance, and scalable scanning solutions. Together, the partners combine Grundium’s innovation-driven scanner technology with Bioanalytica’s market knowledge, local presence, and implementation capability to support laboratories moving toward end-to-end digital workflows.
As demand grows for faster turnaround times, remote consultation, and integrated digital case management, this partnership will help accelerate the transition to efficient, future-ready digital pathology environments across Greece and Cyprus.
Stavros Sougiannis, CEO of Bioanalytica, said:
“For more than 35 years, Bioanalytica has consistently invested in technologies that elevate diagnostic accuracy and workflow performance. In Anatomical Pathology, where we have over two decades of focused expertise, we have already led successful laboratory digitalization projects in Greece.
Our partnership with Grundium is a natural next step in strengthening our digital pathology ecosystem. By integrating the Ocus® scanners into our portfolio, we further enhance our ability to deliver complete, scalable, and clinically meaningful digital solutions to pathology laboratories.”
This partnership reflects a shared commitment to advancing digital pathology adoption in Greece and Cyprus, supported by deep domain expertise and proven implementation experience.
For product information, pricing, and demos of Grundium Ocus® scanners in Greece and Cyprus, please contact Bioanalytica:
https://www.bioanalytica.gr/en/contact/
